<p>Lead author Gita Thanarajasingam joins <em>The Lancet Haematology</em> to discuss the new Commission on assessment and adverse event reporting in haematological malignancies.</p>

Lead author Gita Thanarajasingam joins The Lancet Haematology to discuss the new Commission on assessment and adverse event reporting in haematological malignancies.

Adverse events in haematological malignancies

Lan-Lan Smith, Editor-in-Chief of The Lancet Haematology, and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Share Adverse events in haematological malignancies

Sign up to save your podcasts

Adverse events in haematological malignancies

Adverse events in haematological malignancies